Literature DB >> 28398700

Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms.

Alaina R Martinez1,2, Zeenia Kaul2, Jeffrey D Parvin1, Joanna Groden2.   

Abstract

Cancer cells require telomere maintenance to enable uncontrolled growth. Most often telomerase is activated, although a subset of human cancers are telomerase-negative and depend on recombination-based mechanisms known as ALT (Alternative Lengthening of Telomeres). ALT depends on proteins that are essential for homologous recombination, including BLM and the MRN complex, to extend telomeres. This study surveyed the requirement for requisite homologous recombination proteins, yet to be studied in human ALT cell lines, by protein depletion using RNA interference. Effects on ALT were evaluated by measuring C-circle abundance, a marker of ALT. Surprisingly, several proteins essential for homologous recombination, BARD1, BRCA2, and WRN, were dispensable for C-circle production, while PALB2 had varying effects on C-circles among ALT cell lines. Depletion of homologous recombination proteins BRCA1 and BLM, which have been previously studied in ALT, decreased C-circles in all ALT cell lines. Depletion of the non-homologous end joining proteins 53BP1 and LIG4 had no effect on C-circles in any ALT cell line. Proteins such as chromatin modifiers that recruit double-strand break proteins, RNF8 and RNF168, and other proteins loosely grouped into excision DNA repair processes, XPA, MSH2, and MPG, reduced C-circles in some ALT cell lines. MSH2 depletion also reduced recombination at telomeres as measured by intertelomeric exchanges. Collectively, the requirement for DNA repair proteins varied between the ALT cell lines compared. In sum, our study suggests that ALT proceeds by multiple mechanisms that differ between cell lines and that some of these depend on DNA repair proteins not associated with homologous recombination pathways.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28398700      PMCID: PMC7170175          DOI: 10.1002/gcc.22465

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  92 in total

1.  NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.

Authors:  Dimitri Conomos; Roger R Reddel; Hilda A Pickett
Journal:  Nat Struct Mol Biol       Date:  2014-08-24       Impact factor: 15.369

2.  Identification of a RING protein that can interact in vivo with the BRCA1 gene product.

Authors:  L C Wu; Z W Wang; J T Tsan; M A Spillman; A Phung; X L Xu; M C Yang; L Y Hwang; A M Bowcock; R Baer
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

3.  Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells.

Authors:  Wei Chen; Bo-Kui Xiao; Jun-Ping Liu; Shi-Ming Chen; Ze-Zhang Tao
Journal:  Cancer Sci       Date:  2010-05-08       Impact factor: 6.716

4.  Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination.

Authors:  Satish Sankaran; Lea M Starita; Aaron C Groen; Min Ji Ko; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines.

Authors:  T M Bryan; A Englezou; L Dalla-Pozza; M A Dunham; R R Reddel
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

6.  MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Authors:  Fan Zhang; Gregory Bick; Jung-Young Park; Paul R Andreassen
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

7.  Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA.

Authors:  Jie Liu; Tammy Doty; Bryan Gibson; Wolf-Dietrich Heyer
Journal:  Nat Struct Mol Biol       Date:  2010-08-22       Impact factor: 15.369

8.  Telomere elongation in immortal human cells without detectable telomerase activity.

Authors:  T M Bryan; A Englezou; J Gupta; S Bacchetti; R R Reddel
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

9.  Detection of alternative lengthening of telomeres by telomere quantitative PCR.

Authors:  Loretta M S Lau; Rebecca A Dagg; Jeremy D Henson; Amy Y M Au; Janice A Royds; Roger R Reddel
Journal:  Nucleic Acids Res       Date:  2012-08-25       Impact factor: 16.971

10.  Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells.

Authors:  Samir Acharya; Zeenia Kaul; April Sandy Gocha; Alaina R Martinez; Julia Harris; Jeffrey D Parvin; Joanna Groden
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

View more
  8 in total

1.  Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors.

Authors:  Ming Yuan; Charles G Eberhart; Christine A Pratilas; Jaishri O Blakeley; Christine Davis; Marija Stojanova; Karlyne Reilly; Alan K Meeker; Christopher M Heaphy; Fausto J Rodriguez
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

2.  Constricted migration modulates stem cell differentiation.

Authors:  Lucas R Smith; Jerome Irianto; Yuntao Xia; Charlotte R Pfeifer; Dennis E Discher
Journal:  Mol Biol Cell       Date:  2019-06-12       Impact factor: 4.138

Review 3.  Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability.

Authors:  Sarah J Young; Stephen C West
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-02-17       Impact factor: 8.250

Review 4.  Regulation of Replication Stress in Alternative Lengthening of Telomeres by Fanconi Anaemia Protein.

Authors:  Duda Li; Kailong Hou; Ke Zhang; Shuting Jia
Journal:  Genes (Basel)       Date:  2022-01-20       Impact factor: 4.096

Review 5.  Extrachromosomal circular DNA (eccDNA): an emerging star in cancer.

Authors:  Ruomeng Li; Ying Wang; Jing Li; Xikun Zhou
Journal:  Biomark Res       Date:  2022-07-26

6.  Reliable assessment of telomere maintenance mechanisms in neuroblastoma.

Authors:  Alina Meeser; Christoph Bartenhagen; Lisa Werr; Anna-Maria Hellmann; Yvonne Kahlert; Nadine Hemstedt; Peter Nürnberg; Janine Altmüller; Sandra Ackermann; Barbara Hero; Thorsten Simon; Martin Peifer; Matthias Fischer; Carolina Rosswog
Journal:  Cell Biosci       Date:  2022-09-24       Impact factor: 9.584

Review 7.  The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications.

Authors:  Marta Recagni; Joanna Bidzinska; Nadia Zaffaroni; Marco Folini
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

Review 8.  Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance.

Authors:  Yuanliang Yan; Guijie Guo; Jinzhou Huang; Ming Gao; Qian Zhu; Shuangshuang Zeng; Zhicheng Gong; Zhijie Xu
Journal:  J Hematol Oncol       Date:  2020-09-14       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.